SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (417)2/18/2002 2:39:47 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 724
 
<Caption>
SHARES BENEFICIALLY SHARES BENEFICIALLY
OWNED SHARES BEING OWNED
PRIOR TO THE OFFERING OFFERED AFTER THE OFFERING
-------------------------- ------------ -------------------
NAME OF BENEFICIAL OWNER NUMBER % NUMBER %
- ------------------------ ------ - ------ -
<S> <C> <C> <C> <C> <C>
Thomas H. Lee Equity Fund III,
L.P. ............................ 21,749,345(1)(2)(3) 39.0% 3,992,322(22) 17,757,023 31.8%
Credit Suisse First Boston......... 6,572,289(2)(4)(5) 12.0 1,202,505(23) 5,369,784 9.8
J.P. Morgan Partners (BHCA),
L.P. ............................ 4,367,335(2)(6) 8.0 801,670 3,565,665 6.5
Merrill Lynch Entities............. 1,310,205(2)(7)(8) 2.4 240,503(24) 1,069,702 2.0
Paul M. Montrone................... 2,851,007(2)(9) 5.1 416,332 2,434,675 4.4
Paul M. Meister.................... 1,760,108(2)(10) 3.2 270,056 1,490,052 2.7
David T. Della Penta............... 524,387(2)(11) * 16,879 507,508 *
David V. Harkins................... 108,210(2)(12) * 19,863(25) 88,347 *
Kevin P. Clark..................... 110,100(2)(13) * 21,380 88,720 *
Todd M. DuChene.................... 107,963(2)(14) * 21,136 86,827 *
Scott M. Sperling.................. 54,105(2)(15) * 9,932(26) 44,173 *
Anthony J. DiNovi.................. 54,105(2)(16) * 9,932 44,173 *
Robert A. Day...................... 27,758(17) * -- 27,758 *
Kent R. Weldon..................... 8,115(2)(18) * 1,490 6,625 *
Mitchell J. Blutt, M.D.(6)......... -- -- -- -- --
Michael D. Dingman (19)............ -- -- -- -- --
All directors and executive
officers as a group (12
individuals)..................... 5,605,858(2)(20)(21) 9.9% 787,000 4,818,858 8.5%
</Table>

43
<PAGE>

<Table>
<Caption>
SHARES BENEFICIALLY SHARES BENEFICIALLY
OWNED SHARES BEING OWNED
PRIOR TO THE OFFERING OFFERED AFTER THE OFFERING
-------------------------- ------------ -------------------
OTHER SELLING STOCKHOLDERS(27) NUMBER % NUMBER %
- ------------------------------ ------ - ------ -
<S> <C> <C> <C> <C> <C>
Michael Brown...................... 92,540 * 6,411 86,129 *
Thomas Evangelista................. 39,305 * 6,049 33,256 *
Robert Forte....................... 72,821 * 23,400 49,421 *
Jeffrey Gleason.................... 51,329 * 19,844 31,485 *
Kenneth J. Hessler................. 13,448 * 2,028 11,420 *
Leroy Hood......................... 52,785 * 10,000 42,785 *
Bradley Mahood..................... 24,199 * 6,005 18,194 *
Carolyn Miller..................... 23,376 * 1,989 21,387 *
Paul Patek......................... 145,163 * 25,135 120,028 *
Neil Perlman....................... 67,502 * 13,737 53,765 *
Charles Rohlmeier.................. 12,072 * 2,477 9,595 *
John R. Sasso...................... 42,615 * 22,615 20,000 *
Carlton G. Stott................... 13,810 * 1,886 11,924 *
Albert Strausser III............... 25,991 * 3,013 22,978 *
Steven Shulman..................... 75,740 * 10,000 65,740 *
Michael Toner...................... 86,040 * 12,628 73,412 *
</Table>

- ---------------

* Less than 1%



To: scaram(o)uche who wrote (417)2/19/2002 12:23:03 PM
From: richardred  Read Replies (2) | Respond to of 724
 
Richard: I agree very much. The ball is in FSH court,but they have time on their side. This pasted part of the press release. Exclusive distribution to Fisher for three years certainly does safeguard NBSC from other interested parties. This with 33% of NBSC stock in friendly hands gives the board leverage at what a fair price would be, should the board be thinking of selling out. A big parent certainly lowers risks to future capital funding, and to any retirement plans Mr Freedman might have. The good thing is, if earnings continue to increase, FSH just might want to talk before 3 years is up. A stock deal, instead of cash could help deal with the capital gains issues for board members, with a cash buy out of options for near term cash proceeds. From my personal experience, most buy outs happen with companies on the upswing. NBSC is definitely on the upswing. A floating of new debt by Fisher would definitely be a good sign.

RR

"Additionally, we have successfully negotiated a three-year contract extension of our exclusive distribution agreement with Fisher Scientific International, lending further stability to our global presence. And perhaps most importantly, we have begun 2002 unfettered by non-core investments, giving us the opportunity to focus on our core business which should lead to solid growth in both sales and earnings as we move forward," Freedman concluded